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Tuesday, February 18, 2014 563aaffect of OM on the actin-activated power-stroke. These results show that OM
has a direct effect on the power-stroke structural transition that drives force
generation in muscle, thus providing structural insight into the mechanism of
this new potential therapy for heart failure. Our results also highlight the utility
of structure-based time-resolved FRET and EPR assays for the discovery and
characterization of allosteric enzyme modulators.
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Impact of Regulatory Light Chain Phosphorylation on the Stiffness of a
and b Myosin
Gerrie P. Farman, Jeffery R. Moore.
Boston University, Boston, MA, USA.
It has been demonstrated that the phosphorylation of the RLC can also aid in
the attachment of myosin heads to actin. Moreover, it has been demonstrated
that phosphorylation of the RLC is altered during heart failure progression.
Here we examined the role of the RLC, and its phosphorylation, on the
motility of a and b Myosin. We characterized the strain dependent kinetics
of both myosins by analyzing the dependence of velocity on load using
increasing amounts of a-actinin up to 10 mg/ml. As expected, a-myosin,
both phosphorylated and dephosphorylated, had a faster actin sliding velocity
than b-myosin over the majority of a-actinin concentrations, while phosphor-
ylation of the b-myosin had no significant impact on the actin sliding velocity.
Interestingly, although phosphorylation of
a-myosin significantly reduced the un-
loaded sliding velocity it, increased veloc-
ity under loaded conditions (See Figure).
These results suggest that the phosphory-
lation of the RLC acts at the molecular
level to stiffen the lever arm of myosin
aiding in both myosin head attachment
and power stroke.2845-Pos Board B537
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Familial Hypertrophic Cardiomyopathy (FHC) is characterized by left ven-
tricular hypertrophy that can often be preceded by diastolic dysfunction. The
clinical presentation of the disease varies from asymptomatic to progressive
heart failure to sudden cardiac death. FHC is caused by mutations in genes
that encode for all major sarcomeric proteins. There are 12 known FHC-
linked mutations in the myosin regulatory light chain (RLC). The RLC
mechanically stabilizes the myosin lever arm, which is crucial to myosin’s
ability to transmit contractile force. Two FHC mutations, N47K and R58Q,
located in the RLC Ca2þ-Mg2þ site have previously been shown to reduce
actin filament velocity under load, stemming from a more compliant lever
arm (Greenberg et al., PNAS add details 2010). In contrast, phosphorylation
of the RLC can impart stiffness to the myosin lever arm. We hypothesized
that phosphorylation of the N47K-RLC may mitigate distinct mutation-
induced structural and functional abnormalities. To generate mutant
b-myosin, native pig RLC was depleted from porcine cardiac myosin
heavy chain and reconstituted with mutant N47K or wild-type human
RLC. In the work presented here, in vitro motility assays were utilized to
investigate the effects of RLC phosphorylation on the N47K-RLC mutant
phenotype in the presence of an a-actinin frictional load. Consistent with
previous findings, myosin bearing the N47K mutation reduced actin sliding
velocity compared to WT when incubated with a-actinin, resulting in a 25%
reduction in force production. Phosphorylation of N47K mutant myosin
increased sliding velocity and restored force production to WT values.
These results point to RLC phosphorylation as a potential target to amelio-
rate the FHC RLC phenotype at the molecular level. Supported by AHA-
12PRE11910009 (AK), 10POST3420009 (PM), NIH- HL071778 &
HL108343 (DSC) and HL077280 (JM).
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Cardiac and skeletal muscle myosins have the central role in contraction
transducing ATP free energy into the mechanical work of moving actin intransduction/mechanical coupling. Inheritable cardiomyopathies are more
frequently linked to myosin mutations than other sarcomeric proteins. Hered-
itary skeletal myopathies linked to myosin are less common. They lead to
muscle weakness or affect myosin isoforms expressed during development
leading to arthrogryposis syndromes. Myosin has a motor domain containing
ATP and actin binding sites and light chains stabilized lever-arm that un-
dergoes rotation impelling bound actin. The lever-arm converts torque gener-
ated in the motor into linear displacement (step-size). Relative myosin and
actin filament sliding is modeled in vitro with a motility assay quantitating
actin filament translation over a myosin coated surface. A novel quantum
dot super-resolution in vitro motility assay confirmed a 5 nm step-size for
fast skeletal myosin while b cardiac myosin (bMys) had multiple unitary
steps, most frequently 5 and 8 nm, and a rare 3 nm displacement. The myosin
lever-arm is stabilized by bound essential and regulatory light chains (ELC
and RLC). RLC phosphorylation at S15 is linked to modified lever-arm me-
chanical characteristics contributing to disease and to myosin filament based
contraction regulation. We have studied the effect of RLC phosphorylation on
the step-size of porcine bMys. Phosphorylated bMys has ~85% of the myosin
phosphorylated. We find RLC phosphorylation causing the distribution of
longest step increasing from 37% to 71%. This dramatic re-distribution of
step-sizes provides significant gain in average step-size. The results indicate
a mechanism for contraction regulation by step-size adaptation using post-
translational modification of the myosin filament via RLC phosphorylation.
Research supported by R01AR049277, R01HL095572 and the Mayo
Foundation.
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The effect of A13T (alanine to threonine) hypertrophic cardiomyopathy mu-
tation in the myosin regulatory light chain (RLC) was examined in working
ex-vivo myofibrils from the hearts of transgenic (Tg) mice. Myofibrillar
actin was labeled with a fluorescent dye. A small volume within the
I-band (?1 fL), containing on average 3-4 actin molecules, was observed
by confocal microscopy. The myofibrils were cross-linked with EDC
[1-ethyl-3-[3-(dimethylamino) propyl] carbodiimide] to prevent shortening
during muscle contraction. Working myosin cross-bridges cause actin to un-
dergo the cyclic fluctuations of orientation, which were measured by
recording the polarization of fluorescent light emitted by the actin-bound
fluorophore. The autocorrelation function of fluctuations of polarized fluo-
rescence contains information about the kinetics of motion, which were
found to be very different for left vs. right ventricles. The center of distri-
bution of orientations of transition dipoles during contraction were very
different for the Wild Type (WT) and mutated (MUT) ventricles, but their
skewness and kurtosis were the same. The distribution of orientations
measured in contracting WT myofibrils could be fitted by at least two
Gaussians reflecting a pre- and post power stroke states of the myosin
cross-bridges. However, the distribution of MUT myofibrils showed only
one Gaussian relationship suggesting that the hypertrophic phenotype asso-
ciated with the A13T-RLC mutation might be characterized by a loss of the
pre-power stroke state.
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Cross-bridge (XB) kinetics and the degree of order were examined in con-
tracting myofibrils from the ex-vivo left ventricles of transgenic (Tg) mice
expressing Familial Hypertrophic Cardiomyopathy (FHC) Regulatory Light
Chain (RLC) mutation K104E. Since the kinetics and degree of order are
best studied when an individual XB makes a significant contribution to the
564a Tuesday, February 18, 2014overall signal, the number of observed XBs was minimized to ~20. Auto-
fluorescence and photobleaching were minimized by labeling the myosin
lever arm with a relatively long-lived red-emitting dye containing a chromo-
phore system encapsulated in a cyclic macromolecule. We show that the
K104E mutation, when compared with Wild Type (WT) ventricles, had
significant effect on both the kinetics of the interaction between actin and
myosin and on the degree of order of the myosin lever arm. In particular,
the K104E mutation increased the rate of XB binding to thin filaments and
the rate of execution of the power stroke, while decreasing the rate of
XB dissociation from actin. This implies that the mutated ventricle may be
prone to decreased maximal tension and increased muscle relaxation time
suggesting a potential for diastolic dysfunction in patients. Mutated XBs
were significantly better ordered during steady-state contraction and
during rigor but mutation had no effect on the degree of order in relaxed
myofibrils.
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A recent exciting development in cardiac research is the ability to do mechan-
ical experiments on intact isolated cardiac myocytes. Here we mimic cardiac
PV loops by imposing a ‘pre-load’ and ‘after-load’ on the myocyte. For these
experiments we developed a new generation force transducer as currently
available force transducers were not sufficiently sensitive or had insufficiently
stable base line levels to achieve force control. A cantilever with a spring con-
stant of 7 Nm is interrogated using an interferometer via an optical fiber. The
resolution of the interferometer/probe system is 2nm, resonance frequency >
2 kHz and force resolution < 10 nN. As the probe is small enough to be fully
submerged in water, variations in solution level have no effect on the force
measurement, resulting in a stable baseline (drift < 50 nN over a 10 minute
period at 21C). Software was written to take in the signal from the force trans-
ducer, process it and return a signal to a linear motor that could stretch or
shorten the myocyte in order to control force levels. Using this software we
were able to achieve a two-sided force clamp (setting ‘pre-load’ and ‘after-
load’ ) to measure work loops and re-create the Frank-Starling relation at
the single cell level. Experiments show that in isolated cardiac mouse myo-
cytes residual active force at the end of diastole limits the effective work
the mycoyte can produce. Small concentrations of BDM, thought to inhibit
strong crossbridge formation by stabilizing weak cross bridges, allow the my-
ocyte to relax at end-diastole, shifting the pre-load-sarcomere length relation
upwards. The resulting increase in length dependent activation outweighs the
effects of crossbridge inhibition, leading to strongly increased mechanical
work per contractile cycle.
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Intact cardiomyocytes are increasingly being used to investigate the molecular
mechanisms of contraction and to screen new therapeutic compounds. The
function of the cardiomyocytes is often measured from the calcium transients
and sarcomere length profiles. We studied the role of experimental tempera-
ture and transmural region on indices of function in freshly isolated, unloaded
cardiomyocytes. Intact cardiomyocytes were isolated from the sub endocar-
dium, mid myocardium and sub epicardium of 3 month old Sprague-
Dawley rats. Myocytes from each region were studied at 25, 31, and 37C.
Cytosolic calcium transients were measured using Fura-2 fluorescence while
sarcomere length shortening and relengthening profiles were measured using
high speed video capture. For both the calcium transients and sarcomere
length profiles, the time to peak and the time to half relaxation decreased
significantly with increasing temperature. Increasing temperature also raised
the minimum and maximum calcium levels of all cells. Of note, there was
a reduced normalized standard deviation (standard deviation divided by the
mean) at higher temperatures for calcium fluorescence amplitudes, time to
peak calcium, and rates of sarcomeric shortening and relengthening. The am-
plitudes and minimum of the calcium transients were significantly dependent
on transmural region, and several sarcomere length parameters exhibited sta-tistical interactions between temperature and transmural region. Together,
these results show that biological variability can be reduced by performing ex-
periments at 37C rather than at room temperature, and by isolating cells from
a specific transmural region. Adopting these procedures will improve the sta-
tistical power of subsequent analyses and increase the efficiency of future
experiments.
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Current animal models fail to accurately mimic human heart biology. We
have developed a novel method to isolate viable human cardiomyocytes
(HCMs) from cryopreserved heart transplant donors. The Sydney Heart
Bank is an effective and unique resource for isolating HCMs from donors
as young as 2 months to 65 years. Preliminary data were collected from 2 do-
nors aged 4 and 59 years. Left ventricle (LV) samples were frozen (196C)
after being excised by transplant surgeons. LV tissues stored for 48 and 30
months, respectively, were then warmed gradually over 24 hours to 37C.
300 mm thick cryosections were digested with collagenase type B and D [Mol-
lova et al.. 2013 PNAS. 110:1446], gently agitated and then plated. Cell
viability of isolated HCMs was evaluated using CellTracker CMFDA and
calcein-AM. Our findings showed that isolated HCMs are metabolically active
and viable. HCMs that were metabolically challenged using FCCP (trifluoro-
carbonylcyanide phenylhydrazone) increased their oxygen consumption.
Immunohistochemical analyses using antibodies against cardiac markers
showed that isolated HCMs express sarcomeric alpha-actinin, connexin43
and cardiac troponin T. Addition of BDM (2,3-butanedione monoxime, an in-
hibitor of myosin ATPase activity) allowed a much higher yield of viable
HCMs (20-25% compared to 5% in the absence of BDM). However, the
use of BDM in these culture seems to inhibit contractility of freshly isolated
HCMs. Current studies are investigating optimal culture conditions to control
contractility and viability of HCMs that will be used to replace current animal
models. Taken together, our studies show that viable HCMs can be isolated
and cultured from LV samples and may be used to investigate cardiomyocyte
biology and pathology.
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We recently demonstrated the abundant presence of cardiomyocytes in the
wall of thoracic veins of adult mouse and rat (Kracklauer, Feng, Jiang,
Lin, Lin, Jin, FEBS J. 280:880-91, 2013). The highly differentiated
morphology and myofilament protein expression of the venous cardiomyo-
cytes suggested contractile functions. Here we further investigated the
contractility of mouse and rat azygos venous rings in comparison with that
of atrial strips and ventricular papillary muscle. X-gal staining of transgenic
mouse vessels expressing lacZ under cloned cardiac troponin T promoter
demonstrated that the venous cardiomyocytes are discontinuous from atrial
myocardium and longitudinally aligned in the wall of thoracic veins perpen-
dicular to the vessel axis. Histology study showed striation patterns in the
venous cardiomyocytes, which indicate encirclement orientation of myofi-
brils in the vessel wall. Mechanical studies found that mouse and rat azygos
veins produce strong cardiac type twitch contractions when stimulated by
electrical pacing in contrast to the weak and slow smooth muscle contrac-
tions induced using 90 mM KCl. The twitch contraction and relaxation of
rodent azygos veins further exhibited cardiac type beta-adrenergic responses.
Quantitative characterization showed that the contractions of venous cardio-
myocytes are slightly slower than that of atrium muscle but significantly
faster than that of ventricular papillary muscle. These novel findings indicate
that the cardiomyocytes in rodent thoracic veins possess fully differentiated
cardiac muscle phenotype despite their anatomical and functional separation
from the heart.
